Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine vs remimazolam for prevention of propofol injection pain during general anesthesia
ChiCTR2000039704Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine and remimazolam (3 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Pain presence. Started Nov 2020; status: recruiting.
02
Drugs
lidocaineremimazolam
Beyond the preview
Go deeper on ChiCTR2000039704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039704.